Related Experiment Video
Updated: Jul 19, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Mechanical thrombectomy options in complex percutaneous coronary interventions
Robert V Kelly1, Mauricio G Cohen, George A Stouffer
1Division of Cardiology, University of North Carolina, Chapel Hill, NC 27517, USA. rkelly@med.unc.edu
Insights
Managing thrombus-containing lesions during percutaneous coronary interventions (PCI) presents challenges. This review explores pharmacological and mechanical strategies, including embolic protection devices, to improve outcomes in PCI.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Medicine
Background:
- Percutaneous coronary interventions (PCI) in thrombus-containing lesions carry high risks of complications and poor long-term vessel patency.
- Technical challenges include coronary no-reflow and distal embolization, necessitating advanced management strategies.
Purpose of the Study:
- To examine current approaches for managing thrombotic lesions during PCI.
- To review the evidence supporting various mechanical thrombectomy options for interventional cardiologists.
Main Methods:
- Review of pharmacological strategies (e.g., glycoprotein IIbIIIa inhibitors).
- Analysis of mechanical strategies, including embolic protection devices and thrombectomy catheters.
- Evaluation of clinical outcomes associated with different interventions.
Main Results:
- Pharmacological agents reduce thrombus propagation and improve coronary blood flow.
- Mechanical devices aim to improve coronary blood flow and myocardial perfusion, with variable clinical outcome data.
- Embolic protection devices show benefit in saphenous vein graft (SVG) PCI, but their role in native coronary arteries requires further investigation.
Conclusions:
- Effective management of thrombotic lesions in PCI requires a combination of pharmacological and mechanical approaches.
- Mechanical thrombectomy options offer potential benefits, but their clinical impact and optimal use, especially in native arteries, warrant further research.
Abstract:
Percutaneous coronary interventions (PCI) of thrombus-containing lesions are associated with an increased risk of acute complications and poorer long term vessel patency. Dealing with these vessels provides many technical challenges, especially with the significant risk of coronary no reflow and distal embolization. Pharmacological strategies, including intravenous and intracoronary glycoprotein IIbIIIa inhibitors reduce intracoronary thrombus propagation, improve TIMI flow and are associated with a reduction in adverse event rates. Mechanical strategies (particularly embolic protection and thrombectomy catheters) help to improve coronary blood flow and myocardial perfusion. However, their impact on clinical outcomes is less clear. The use of embolic protection devices is associated with better perfusion, blood flow, and clinical outcomes among patients undergoing saphenous vein graft (SVG) PCI. However, the role for these devices in primary PCI and native coronary artery interventions is uncertain. This study examines the current approaches to manage thrombotic lesions during PCI and reviews the evidence in support of the different mechanical thrombectomy options that are available to the interventional cardiologist.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care